Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-30

Clinical Trial Update: Phase 3 Clinical Trial of Teriparatide in Japan [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of teriparatide for osteoporosis conducted in Japan has completed, with results posted on 2009-09-30.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2009-09-30